Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue - Other
Ratios

Bolt Biotherapeutics (BOLT) Preferred Shares Issued (2020 - 2021)

Bolt Biotherapeutics' Preferred Shares Issued history spans 2 years, with the latest figure at $51.9 million for Q1 2021.

  • For Q1 2021, Preferred Shares Issued changed N/A year-over-year to $51.9 million; the TTM value through Dec 2021 reached $51.9 million, changed N/A, while the annual FY2021 figure was $51.9 million, 25.76% up from the prior year.
  • Preferred Shares Issued for Q1 2021 was $51.9 million at Bolt Biotherapeutics, up from -$276000.0 in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $51.9 million in Q1 2021 and bottomed at -$276000.0 in Q3 2020.